BioSpace News Archive

Policy

Recor Medical and Otsuka Medical Devices Announce Positive Vote from U.S. Food and Drug Administration (FDA) Advisory Committee Meeting on the Paradise™ Ultrasound Renal Denervation System for the Treatment of Hypertension

Recor Medical, Inc. and its parent company, Otsuka Medical Devices Co., Ltd. announce the U.S. Food and Drug Administration Circulatory Systems Devices Panel of the Medical Devices Advisory Committee met to discuss the pre-market approval application for the Paradise™ Ultrasound Renal Denervation system, indicated to reduce blood pressure in patients with hypertension.

August 22, 2023
·
3 min read
Single-use Bioprocessing Market to Worth USD 84,140 Million by 2032

The global single-use bioprocessing market reached a value of USD 20,960 million in 2022 and is projected to be worth around USD 84,140 million by 2032, experiencing a compound annual growth rate (CAGR) of 15.46% from 2023 to 2032.

August 22, 2023
·
9 min read